‎Comparative Effectiveness Research (CER)

(SLC-004) A Comparative Study of Sodium-Glucose Cotransporter-2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors on Renal Disorders in Type 2 Diabetes Mellitus

(SLC-001) Comparative Effectiveness of Injectable Versus Oral Pre-Exposure Prophylaxis (PrEP) for HIV Prevention

(SLC-002) Comparison of Nephroprotective Effects Between Long- and Short-acting Angiotensin Receptor Blockers in Diabetic Nephropathy: A Real-world Retrospective Study

(C-001) Denosumab Use and Cataract Risk in Patients with Osteoporosis: A Propensity Score-matched Cohort Study

(SLC-008) Impact of Frailty on Risk of Chronic Obstructive Pulmonary Disease Exacerbations and Pneumonia Associated with SGLT2 Inhibitors Compared to DPP-4 Inhibitors and GLP-1 Receptor Agonists in Patients with Type 2 Diabetes

(SLC-007) Longitudinal Changes in Depressive Symptom Severity with Different Antidepressant Classes among People with HIV

(C-002) SGLT2 Inhibitors and Nephrolithiasis Risk in Patients with Type 2 Diabetes: A Cohort Study and Meta-analysis

(SLC-003) Sodium-Glucose Co-Transporter-2 Inhibitor Use and Risks of Exacerbation and Pneumonia in Patients with Chronic Obstructive Pulmonary Disease and Diabetes Mellitus: A Population-Based Cohort Study

(SLC-005) The Association of Glucagon-Like Peptide-1 Receptor Agonists with Depression, Anxiety, and Alcohol Misuse in Individuals with Type 2 Diabetes Mellitus

(SLC-006) The Association of Sodium-Glucose Cotransporter-2 Inhibitors with Cancers in Individuals with Type 2 Diabetes Mellitus